Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised, controlled, phase 3 trial

<p><strong>Background:</strong><br /> The interim analysis of the multicentre New EPOC trial in patients with resectable colorectal liver metastasis showed a significant reduction in progression-free survival in patients allocated to cetuximab plus chemotherapy compared with...

Full description

Bibliographic Details
Main Authors:	Bridgewater, JA, Pugh, SA, Maishman, T, Eminton, Z, Mellor, J, Whitehead, A, Stanton, L, Radford, M, Corkhill, A, Griffiths, GO, Falk, S, Valle, JW, O'Reilly, D, Siriwardena, AK, Hornbuckle, J, Rees, M, Iveson, TJ, Hickish, T, Garden, OJ, Cunningham, D, Maughan, TS, Primrose, JN, Brown, E
Other Authors:	Shablack, A
Format:	Journal article
Language:	English
Published:	Elsevier 2020

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised, controlled, phase 3 trial

Similar Items